When more than one lab tests the same batch, we line up their results side by side. When they match, it is the strongest signal you can get. When they do not, that is information too. Here is what these labs found — you decide.
4 independent labs tested this batch of CJC-1295 (no-DAC) from Injectify. Their purity results ranged from 54.8% to 98.2%.
The labs do NOT agree
That is a wide spread. When labs disagree this much on the same batch, no single certificate tells the whole story.
On the actual amount per vial, the labs were close (4.2 to 5.0 mg).
⚠ One lab came back sharply different from the rest (flagged and highlighted in the table below). It counts toward the range above but is pulled out of the agreement math.
Heads up: our overall RV score may read these labs as close. That is because the score blends purity with other factors and compresses big differences. When you weigh this batch, the raw purity range above is what matters, not the smoothed score.
Scores land close·Poor · 4.9
The two badges above are our blended RV-score view: whether the scores agree, and the overall quality tier. The plain read at the top leads with the labs actual purity numbers, and the full per-lab table is below.
CJC-1295 (no-DAC) from Injectify batch PE2401-613 · cross-tested by 4 independent labs
The blended RV scores land within 0.5 to 1.5 points of each other. The RV score mixes purity with other factors and can read as agreement even when raw purity does not — so weigh the raw purity range shown above.
✓ Batch identity basis: Same physical sample (Finnrick multi-lab program)
All records carry Finnrick (FNR-*) task IDs, meaning one physical vial was routed by Finnrick to multiple labs and each lab tested it independently. This is the strongest basis for 'same batch' — there's no batch heterogeneity between labs because there's no batch difference: it's the same vial.
🧞 Identity caveat — Distinct molecule from CJC-1295 DAC (DAC adds Drug Affinity Complex → days-long half-life). Bare 'CJC-1295' resolves here per peptide-research market convention: ≥99% of bare-term COAs are no-DAC (Mod GRF 1-29). Vendors advertising DAC form state so explicitly. If a record's DAC/no-DAC matters for downstream analysis, verify against the COA notes — do not blindly trust this resolution.
Same method, results still diverge — investigate. All labs reported HPLC but results diverge — batch heterogeneity, calibration drift, or sample handling worth investigating. When labs share the analytical approach but the numbers don't line up, the divergence is doing real work and deserves a closer look.
Outlier detected. One or more records in this group are statistically unusual (|z-score| > 2.0) compared to the others. Highlighted rows above show the flagged tests. Common causes: differing test methods, lab calibration drift, sample handling, or a genuinely heterogeneous batch.
Why this matters: A single COA is one lab's answer from one method on one sample. Multiple labs reveal the pattern. When labs converge on the same answer, that's strong cross-validation. When they diverge — especially on content while agreeing on purity — the difference is often method-driven (different quantitation basis) but sometimes signals real product variation. ResearchVerify is the only platform that surfaces both cases automatically across thousands of cross-tests.